Physician profile
Beje Thomas
NPI 1225214471
$4,496.97
in general payments reported to CMS, 2019-2025
5 companies · $4,181 in 2025
The $4,181 reported for 2025 was more than what 93% of Nephrology (Internal Medicine) providers received nationally (typical 2025 total: $311).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $21.58 · 2023: $24.00 · 2024: $270 · 2025: $4,181.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $3,900 · Food and Beverage: $575.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $3,900.00 |
| Food and Beverage | $575.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $3,900.00 | 2025 | |
| Sanofi-Aventis U.S. LLC | $337.97 | 2024-2025 | |
| Mallinckrodt Hospital Products INC. | $155.38 | 2023-2024 | Terlivaz, Acthar |
| Veloxis Pharmaceuticals, INC. | $89.64 | 2022-2025 | Envarsus |
| Kamada LTD. | $13.98 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Beje Thomas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.